A study of near-infrared fluorescence imaging in lung cancer

Comparison and clinicopathological factors of fluorescence imaging in lung cancer with near-infrared-I/II windows

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057666

Enrollment

Unknown

Registered

2022-03-15

Start date

2022-03-01

Completion date

Unknown

Last updated

2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

1:Indocyanine green (5mg/kg) was injected intravenously 24 hours before operation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Lung cancer patients undergoing radical resection in our center; 2.Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with abnormal liver function or indocyanine green allergy; 2.And the researchers believe that the subjects may not be able to complete the study or comply with the requirements of the study (due to management or other reasons).

Design outcomes

Primary

Measure	Time frame
Signal-to-background ratio;	—

Countries

China

Contacts

Public ContactJian Zhou

Department of Thoracic Surgery, Peking University People’s Hospital

zhoujian@bjmu.edu.cn+86 13811765740

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026